Instead, in vitro TRIB1 knockdown in a model of human TAMs revealed that inhibition of TRIB1 enhances expression of oncogenic cytokines in TAMs, which are involved both in cancer cell survival and immune suppression. The gene discussed is TRIB1; the disease is cancer.